We examined the association between cow's milk allergy (CMA) and juvenile idiopathic arthritis (JIA). The material for this case-control study was collected from national registers of all children born in Finland between 2000 and 2010 and diagnosed with JIA (n = 1,298) and age-, sex-, and place-matched controls (n = 5,179). We identified 235 children with CMA; 66 of these children also had JIA. A conditional logistic regression analysis was performed to evaluate the association between CMA and JIA and to test whether exposure to antibiotics would be a covariate for this association. In boys (but not in girls), a diagnosis of CMA and the use of hypoallergenic formula in infancy were associated with the later development of JIA (odds ratio = 2.4, 95% confidence interval: 1.6, 3.6). The association was most evident in boys who were diagnosed with JIA before age 3 years or diagnosed with CMA with predominantly gastrointestinal symptoms. There was no statistically significant additive interaction between CMA and antibiotic exposure in the later development of JIA. These associations may reflect impaired maturation of intestinal immunity and integrity in boys with a risk of JIA. Predisposing factors related to JIA pathogenesis seem to display a sex-linked disparity. allergy; arthritis; child; juvenile idiopathic arthritis; matched case-control studies; milk; milk allergy; milk hypersensitivity Abbreviations: API, attributable proportion due to interaction; CI, confidence interval; CMA, cow's milk allergy; JIA, juvenile idiopathic arthritis; OR, odds ratio; RERI, relative excess risk due to interaction; SI, synergy index; SII, Social Insurance Institution.
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Juvenile idiopathic arthritis (JIA) is a group of heterogeneous diseases characterized by long-standing arthritis of unknown origin (1) . While unbalanced interactions between genes and environmental antigens play a role in the pathogenesis of JIA, there is still limited evidence that specific environmental triggers may participate in the pathogenetic process via contact with mucosal peripheral immunity (2) . A healthy mucosal immune system does not display immunological reactions against nutritional antigens, but it distinguishes nutritional antigens and nonharmful microbes from pathogens (3) . This hyporesponsiveness is called "oral tolerance," and it involves specific suppression of cellular and humoral immune responses to ingested antigens (4) . Colonization by intestinal microbiota drives the normal development of mucosal tolerance in infancy (3), but this process can be disrupted by nutritional agents and antibiotics, which may affect mucosal flora and permeability (5) . Exposure to antibiotics has been linked with the risk of both cow's milk allergy (CMA) (6) and JIA (7, 8) , and furthermore, increased intestinal permeability (9, 10) has been reported in both of these diseases. Alterations have been found in the fecal microbial flora, such as a high abundance of bacteroides as compared with controls (11, 12) .
CMA has been considered to be one of the first indications of an aberrant inflammatory response in early life (13) . It has been associated with later autoimmune manifestations, including inflammatory bowel disease (14) or autoimmunity against beta cells (15) . In addition, intestinal intolerance to food proteins has been associated with rheumatic diseases. In rheumatoid arthritis, antibodies against different nutritional proteins, including cow's milk and soy proteins, have been detected in the jejunum (16) . In our earlier work and in a recent British study on children suffering from gastrointestinal symptoms, JIA patients showed evidence of low-grade mucosal inflammatory activation more often than healthy controls (17) (18) (19) (20) . In our earlier investigations, we detected signs of inflammatory activation, such as intestinal lymphonodular hyperplasia, increased expression of intraepithelial gamma delta-positive T cells in the small intestine, cytotoxic lymphocytes in the duodenum, and human leukocyte antigen D-related expression in unexpected locations in the ileal mucosa (17) (18) (19) . A similar alteration has been previously documented in delayedtype food allergies (21) (22) (23) (24) .
In some case reports, elimination of cow's milk from the diet was claimed to improve the course of arthritis in JIA patients (25) (26) (27) . In a recent British study (20) , almost one-third of the JIA cases with gastrointestinal symptoms exhibited eosinophilic gastrointestinal infiltrations. Such lesions are typically treated with a restriction diet, including elimination of cow's milk (28) . Therefore, our aim was to study whether there would be any association between CMA in infancy and the later appearance of JIA. Since antibiotics have been reported to be a risk factor for both JIA and CMA (7, 8) , we also determined whether the link between CMA and JIA was associated with exposure to antibiotics.
METHODS

Data sources and study population
Data were obtained from 3 Finnish national registers and were linked by means of the unique personal identity codes (including date of birth and sex) that are assigned to all Finnish citizens shortly after birth or immigration (29) . Cases of JIA and CMA were identified through the Special Reimbursement Register, a register of reimbursement for drug costs maintained by the Social Insurance Institution (SII) of Finland (30, 31) . The controls for children with JIA were sampled from the Population Register Centre (32) . Information on purchased hypoallergenic infant formula (soya infant formula included) and antibiotics was obtained from the Finnish Prescription Register (30) , which is also maintained by the SII. All hypoallergenic formulas and drugs prescribed by physicians and reimbursed through the National Sickness Insurance Scheme are registered in the Finnish Prescription Register, which has been in operation since 1994 (30) . During the time of this study in Finland, hypoallergenic formulas (soya infant formula included) were sold only in pharmacies, and antibiotics for outpatients were prescription-only and available exclusively through pharmacies.
Identification of patients with JIA
In brief, we identified all of the children born in Finland between January 1, 2000, and December 31, 2010, who had received a special reimbursement for the cost of antirheumatic drugs, based on a diagnosis of JIA (International Classification of Diseases, Tenth Revision, code M08) by the end of December 2012. In Finland, patients with chronic diseases, including JIA, are entitled to a higher refund for the costs of their medications (31) . The International League of Associations for Rheumatology criteria for the diagnosis of JIA were used (33) . The administrative process for decision-making by the SII takes a few weeks. In addition to the diagnosis of chronic diseases, register information includes the date of the special refund decision. The drug certificates are checked by a medical examiner, physician, or pharmacist at the SII before entitlement to a special refund can be granted. This particular date was used as a proxy indicator for the date of JIA diagnosis and is defined here as the index date for both the cases and their respective controls. In this article, we use the term "date of JIA diagnosis." For each incident case, 4 eligible control children (with no special reimbursement for JIA) were randomly selected and individually matched according to date of birth (during the same quarter of the year), sex, and municipality of residence at birth. In 7 cases, fewer than 4 controls could be found. Thus, we identified 1,298 cases and 5,179 matched controls.
Identification of subjects with CMA
In Finland, infants who need hypoallergenic formulas in the management of CMA are entitled to special reimbursement. Before this is granted, the SII requires a pediatrician-signed certificate indicating that the diagnosis of CMA (International Classification of Diseases, Tenth Revision, code K52.2 or L27.2) has been made according to the approved criteria. During the period of this data registration, the diagnostic criteria for CMA included a clinical examination with details on history, symptoms suggestive of CMA, and an open elimination-challenge test for cow's milk (34) . Special reimbursement applications and certificates for CMA are reviewed by a clinical specialist-in most cases, a pediatrician working in the local SII office. In our study population, the entitlement to a special refund for CMA was granted to 74 patients with JIA and to 197 control children, but not all of the parents of these subjects made regular purchases of hypoallergenic formula. In order to better ensure the accuracy of the identification of incident CMA cases, we also extracted information concerning all outpatient purchases of hypoallergenic formula from the Finnish Prescription Register. When at least 10 packages of hypoallergenic formula had been purchased for a child and she/he was entitled to reimbursement for CMA, then she/he was considered to have definite CMA. With this more stringent evaluation, 66 cases with JIA (5.1%) and 169 controls (3.3%) were judged to have CMA ( Table 1 ). The link between CMA and JIA was reevaluated separately in 3 groups according to age at diagnosis of JIA: very early onset (age <3 years), age 3-5.9 years, and age ≥6 years, because the JIA incidence peak can be found at less than 3 years of age (35, 36) . In addition, an age of ≥6 years is part of the criteria for diagnosis of the "enthesitis-related arthritis" category of JIA. Its pathogenesis has been proposed to be triggered by intestinal mucosal factors (37, 38) .
Relationship between exposure to infant formula and later diagnosis of JIA Since it has been reported that consumption of hypoallergenic formula could modify intestinal mucosal flora (39), we evaluated whether the risk of JIA increased with an increasing volume of consumed hypoallergenic formula (in liters). (Table 1) . For children with no purchases of hypoallergenic formula, the volume was set to zero.
Covariate analysis of the association between CMA and JIA Based on previous studies (7, 8) , we suspected that early or repeated exposure to antibiotics could be a covariate of the association between CMA and JIA. Therefore, we extracted information on all antibiotics (Anatomical Therapeutic Chemical code J01-antibacterials for systemic use) purchased for the outpatients from birth to the date of JIA diagnosis and the corresponding index date of the controls. Use of antibiotics was classified into 2 groups: no purchases versus ≥1 purchase of any antibiotic.
Statistics
The data consisted of individually matched sets with 1 case and 4 controls. The difference in proportion was tested with the binomial standardized normal deviate test. We evaluated the association between exposure to formula usage for CMA and diagnosis of JIA by means of univariate conditional logistic regression analysis. To test the relationship between CMA and exposure to antibiotics, a new 4-class variable was created. The reference category was no CMA and no antibiotics purchased up to the diagnosis of JIA, and the highest rank was CMA and at least 1 antibiotic purchase prior to the diagnosis of JIA (see Web Figure 1 , available at https://academic.oup.com/ aje). A multivariate conditional logistic regression analysis was performed to investigate the relationship of CMA in infancy to the later development of JIA after adjustment for exposure to antibiotics. To evaluate the presence and importance of the main symptoms of CMA in the gastrointestinal tract or in the skin, only those matched sets in which either a child with JIA or at least 1 control child had CMA were included in the conditional logistic regression analysis. The strengths of the associations were quantified using matched odds ratios with 95% confidence intervals. The additive interaction between CMA and antibiotics for JIA was evaluated via 3 measures: the relative excess risk due to interaction (RERI), the attributable proportion due to interaction (API), and the ratio between the combined effect and individual effects, that is, the synergy index (SI) (40, 41) . In the absence of additive interactions, RERI = 0, API = 0, and SI = 1. Statistical analyses were performed with IBM SPSS Statistics for Windows, version 22.0.0 (IBM Corporation, Armonk, New York), and Stata/IC 13.1 for Windows (StataCorp LP, College Station, Texas).
Ethical considerations
Ethical approval was not necessary, since we used only encrypted register data and did not contact the study subjects, who were unidentifiable.
RESULTS
We analyzed a total of 1,298 children with JIA and 5,179 matched control children. The median age at diagnosis of JIA was 3.8 years (range, 0.7-12.9 years), and 37% of the cases were boys (Table 1) . In Finland during the years 2010-2012, a total of 332 girls and 213 boys below age 11 years contracted JIA. Thus, during that 3-year period (2010-2012), the mean annual incidence of JIA by the age of 11 years was 34/ 100,000 for girls and 21/100,000 for boys.
The total number of CMA cases among all 6,477 study subjects was 235 (66 with JIA and 169 in controls). By the age of 1 year, the cumulative incidence of CMA in our control cohort was 3.0%; by the age of 2 years, it was 3.3%. All CMA diagnoses were made before the possible diagnosis of JIA and also before the corresponding index date of the controls. The median age at diagnosis of JIA in children who also had CMA was 4.6 years (range, 1.3-12.6 years), and slightly more (56%) of the cases with both CMA and JIA were boys. In children with JIA, CMA was more common in boys than in girls (7.8% vs. 3.5%; P = 0.001) ( Table 1) . Among those boys with CMA in infancy, there was a statistically significant risk of development of JIA (odds ratio (OR) = 2.4, 95% confidence interval (CI): 1.6, 3.6) (Web Figure 1 ). This association was not evident in girls (OR = 1.1, 95% CI: 0.7, 1.7). Additionally, every 10-L purchase of hypoallergenic formula increased the risk of JIA by 2% in boys (OR = 1.02, 95% CI: 1.01, 1.03), but there was no similar increase in JIA risk in girls.
CMA was a risk factor for the development of JIA, particularly in those boys who were diagnosed with JIA before the age of 3 years (OR = 3.8, 95% CI: 1.9, 7.6) ( Table 2) . Adjustment for antibiotic exposure reduced the risk only marginally (OR = 3.5, 95% CI: 1.6, 6.8). At age ≥6 years, the odds ratio of 2.2 (95% CI: 1.0, 4.8) for JIA was nearly significant only in boys (Table 2) . Among boys, those who had CMA with mainly a gastrointestinal manifestation displayed a higher risk of developing JIA than those with predominantly a skin manifestation (OR = 4.4 (95% CI: 1.9, 9.9) vs. OR = 1.8 (95% CI: 1.1, 3.0)) (Web Figure 1) .
Overall, the data comprised 8,559 purchases of antibiotics for cases and 27,374 purchases for controls prior to the diagnosis of JIA. The mean number of purchases of antibiotics was 6.6 (range, 0-81) for cases and 5.3 (range, 0-52) for controls (Table 1) . Among boys, the risk of JIA was highest when both CMA and antibiotic exposure were present (OR = 4.0, 95% CI: 2.3, 6.9) (Web Figure 1) . The effect of antibiotic exposure alone increased the odds of subsequently contracting JIA 1.7-fold in boys (95% CI: 1.2, 2.5) and 1.5-fold in girls (95% CI: 1.2, 1.9) (Web Figure 1) .
Furthermore, in boys, there was a positive but not statistically significant additive interaction between CMA and exposure to antibiotics before the diagnosis of JIA (RERI = 2.2, API = 0.6, SI = 3.8) (Table 3 ). Almost none of the additive effect could be attributed to the impact of CMA alone (4%); 23% was due to the effect of antibiotics alone, and the remaining 73% was estimated as an interaction between CMA and antibiotic use in boys.
DISCUSSION
This register-based case-control study provided data on the risk of JIA development among children suffering from CMA in infancy. CMA preceded the diagnosis of JIA more than twice as often in boys as in girls. Boys with CMA had more than a doubling of their risk of developing JIA when compared with boys without CMA. The risk was most evident in those boys with CMA who developed JIA before the age of 3 years. Boys with CMA manifesting with gastrointestinal symptoms showed a higher risk of developing JIA than those with predominantly skin symptoms. In boys, CMA and antibiotic exposure together quadrupled the risk of developing JIA in comparison with the absence of both of those exposures. There was no interaction between CMA and antibiotic exposure in the development of JIA on either an additive or a multiplicative scale.
Exposure to antibiotics in boys suffering from CMA potentiated the risk of developing JIA. In our previous study, which was carried out in the same study population, we found that both early exposure to any antibiotic and overall exposure to any antibiotic were associated with an increased risk of developing JIA (7). In the current study, this association was found to be more evident in boys. Antibiotics were also reported to be a risk factor for developing CMA in a large Finnish populationbased study (6) . Previous reports (7, 8) and our current investigation support the proposal that in some JIA patients and in children with CMA, environmental factors may modify the development of mucosal tolerance and trigger the development of these diseases. This hypothesis is supported by findings that peripheral tolerance is needed not only to outgrow CMA (42) but also to control autoreactive T cells in rheumatic diseases (43) . In our earlier study, which examined intestinal immune regulation in JIA (17), we observed that patients in clinical remission had greater expression of mucosal antiinflammatory mediators in ileal biopsies than patients with an active disease. Earlier reports supported the findings emerging from our current study. The cumulative incidence of CMA among controls in our study population was about the same as that reported previously (3.3% vs. 2.2%-2.8%) using the open eliminationchallenge test for the diagnosis of CMA (44) (45) (46) . In our control group, CMA was slightly more frequent in boys (3.5%) than in girls (3.1%). The male:female ratio for the prevalence of CMA has also deviated toward males in other European epidemiologic studies (47) but not in North American studies (48) . The annual incidences of JIA observed in this study and derived using the current identification method for the cases during the study period 2000-2007 (49) were rather similar to those (21-22 per 100,000 children aged <16 years) in an earlier register-based study (35) . We also detected the same sex disparity in the appearance of JIA in this study (63% girls) as did Berntson et al. (35) in the earlier study. Our study results are most likely not biased, because similar data collection protocols were used for both patients and controls. We identified JIA cases through the Special Reimbursement Register for drug purchases; therefore, it is possible that some JIA cases with limited symptoms were missed. However, this should not have interfered with the validity of our case-control setting. One could also hypothesize that the current association has been overestimated-that is, a child may be more likely to be referred to a pediatric rheumatologist by a pediatric allergist or vice versa. This is unlikely, since all CMA diagnoses were made before the diagnosis of JIA. In addition, use of the children's cost-free health-care system is high in Finland. Therefore, we considered that Berkson's bias did not exert any meaningful influence on the current association.
Because of the inability to obtain more specific data, the current association could not be compared with the clinical course of JIA or JIA categories (persistent and extended oligoarthritis, seronegative and seropositive polyarthritis, systemic arthritis, enthesitis-related arthritis, psoriatic arthritis, and undifferentiated arthritis). Since CMA conferred a higher risk of subsequent JIA in boys than in girls, we considered the role of different sex distributions in the JIA categories. It is known that the "enthesitis-related arthritis" category of JIA is more prevalent in boys; in fact, one of the criteria for this category is being a boy and contracting JIA at 6 or more years of age (33) . Here, in boys aged ≥6 years, CMA in infancy caused only a nearly significant and marginally increased risk of developing JIA; instead, the risk was strongest in boys who contracted JIA before age 3 years (Table 2) . Thus, the current sex-dependent association cannot be explained by a link between intestinal immune alterations, CMA, and the "enthesitis-related arthritis" category (14, 37, 38) . In Scandinavian countries, low maternal socioeconomic status has been associated with a lower incidence of CMA, but this kind of association has not been documented with JIA (50, 51). Our protocol did not gather data about socioeconomic status, but we matched cases and controls by place of birth to diminish its potential confounding effect and the effect of local differences in treatment practices. Another limitation is that during the study period, the nonblinded eliminationchallenge test was used for diagnosing CMA. In the future, the current epidemiologic risk should be studied using a more comprehensive protocol, and it should combine register data with socioeconomic and clinical information from hospital and outpatient registers. It is most likely that this kind of information would support attempts to upgrade the classification system for JIA, which has been criticized, since it is still lacking categories for some JIA phenotypes (52, 53) .
In the current study, the purchase of a greater volume of hydrolyzed formula was associated with a greater risk of developing JIA. This relationship may be indirect-for example, related to 1) other environmental factors, such as breastfeeding; 2) the effect of the constitution of the hypoallergenic formula on colonization by intestinal flora; and 3) delay in the introduction of other nutrients (54) . With regard to the first possibility, long-term breastfeeding supports the maturation of the intestinal mucosal immune system, but its protective effect on the development of JIA is inconsistent (2) . Recent Finnish studies have revealed a median duration of exclusive breastfeeding of 1.8 months and total breastfeeding of 7 months (55, 56) . Unfortunately, data on rate and duration of breastfeeding were not available here. Secondly, use of low-lactose hydrolyzed infant formula has been claimed to reduce the abundance of lactase-producing bacteria (39) . A trend towards low representation of lactic-acid-producing bacteria was found in JIA patients as compared with controls (12) . Thirdly, CMA may also affect nutrition after the lactation period. It is known that at least immunoglobulin E-mediated CMA may postpone the introduction of other food proteins beyond the optimal period (57) . A delay in the introduction of solid foods may predispose children to later food allergies (55) and altered development of peripheral tolerance (3) .
This epidemiologic case-control study revealed that the appearance of JIA was associated with previous CMA and exposure to antibiotics in boys. Based on these results, it seems that boys and girls exhibit somewhat different risk factors for developing JIA. In the future, studies confirming the sexdependent associations between CMA and JIA are warranted. In conclusion, earlier studies (14, 15) , together with our current findings, link CMA and the risk of developing manifestations of autoimmunity. This is evidence of a possible role for mucosal immunity in the pathogenesis of autoimmune diseases.
